Novellus Ventures Ls1 Gp, Llc
Venture capitalActively deployingHouston · Pre-Seed–Series A · 7 people tracked
Find your way into Novellus Ventures Ls1 Gp, Llc
1,203 people in our graph share verified history with the Novellus Ventures Ls1 Gp, Llc team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Novellus Ventures invests at the early stage in companies transforming healthcare, focusing on diagnostics, med-tech, therapeutics, and digital health that improve how disease is detected, treated, and prevented. The firm evaluates a company's product roadmap, clinical validation plan, regulatory approach, and commercial entry strategy using scientific rigor, operational experience, and a deep clinical network. Its philosophy centers on disciplined evaluation, high-conviction backing, and long-term partnership. Beyond capital, Novellus offers strategic support on regulatory and clinical development pathways and go-to-market execution, curated network access to experts and advisors, operational insight from entrepreneurial experience, and patient long-term partnership through a company's growth.
Source: firm website, verified Sep 1, 2026.
Team · 7 people
from the firm's website & curatedFrequently asked questions
- What stage does Novellus Ventures Ls1 Gp, Llc invest at?
- Novellus Ventures Ls1 Gp, Llc invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Novellus Ventures Ls1 Gp, Llc focus on?
- Novellus Ventures Ls1 Gp, Llc focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Novellus Ventures Ls1 Gp, Llc located?
- Novellus Ventures Ls1 Gp, Llc is headquartered in Houston, US.
Similar investors
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
InnoCom Bio Equities manages life science special purpose vehicles, offering investors a diversified portfolio of innovative life sciences technologies and providing seed capital to innovators and founders.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.



